449 related articles for article (PubMed ID: 27914703)
1. Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
Bellur SS; Lepeytre F; Vorobyeva O; Troyanov S; Cook HT; Roberts IS;
Kidney Int; 2017 Jan; 91(1):235-243. PubMed ID: 27914703
[TBL] [Abstract][Full Text] [Related]
2. Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
Bellur SS; Troyanov S; Vorobyeva O; Coppo R; Roberts ISD;
Kidney Int; 2024 Jun; 105(6):1279-1290. PubMed ID: 38554992
[TBL] [Abstract][Full Text] [Related]
3. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies.
El Karoui K; Hill GS; Karras A; Moulonguet L; Caudwell V; Loupy A; Bruneval P; Jacquot C; Nochy D
Kidney Int; 2011 Mar; 79(6):643-654. PubMed ID: 21178978
[TBL] [Abstract][Full Text] [Related]
4. The implications of focal segmental glomerulosclerosis in children with IgA nephropathy.
Trimarchi H; Coppo R
Pediatr Nephrol; 2020 Nov; 35(11):2043-2047. PubMed ID: 31773265
[TBL] [Abstract][Full Text] [Related]
5. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
Trimarchi H; Barratt J; Cattran DC; Cook HT; Coppo R; Haas M; Liu ZH; Roberts IS; Yuzawa Y; Zhang H; Feehally J; ;
Kidney Int; 2017 May; 91(5):1014-1021. PubMed ID: 28341274
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of sub classification of focal segmental glomerular sclerosis in Oxford classification of IgA nephropathy.
Yu F; Zhu X; Yuan S; Chen X; Li Z; Qu Z; Liu H; Sun L; Liu F
Ann Med; 2021 Dec; 53(1):587-595. PubMed ID: 33825605
[TBL] [Abstract][Full Text] [Related]
7. Focal segmental glomerulosclerosis in IgA nephropathy: a result of primary podocyte injury?
Cook HT
Kidney Int; 2011 Mar; 79(6):581-583. PubMed ID: 21358653
[TBL] [Abstract][Full Text] [Related]
8. Is it possible to predict parameters of the Oxford classification of primary IgA Nephropathy from clinical laboratory data? Focus on the role of segmental glomerulosclerosis subtypes.
Monteiro MLGDR; Vieira MR; Pereira LHM; Araújo LS; Silva CA; Araújo LB; Rocha LP; Reis MAD; Machado JR
Pathol Res Pract; 2019 Oct; 215(10):152533. PubMed ID: 31320251
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Oxford classification of IgA nephropathy.
Herzenberg AM; Fogo AB; Reich HN; Troyanov S; Bavbek N; Massat AE; Hunley TE; Hladunewich MA; Julian BA; Fervenza FC; Cattran DC
Kidney Int; 2011 Aug; 80(3):310-7. PubMed ID: 21544062
[TBL] [Abstract][Full Text] [Related]
10. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).
Edström Halling S; Söderberg MP; Berg UB
Nephrol Dial Transplant; 2012 Feb; 27(2):715-22. PubMed ID: 21750154
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.
Coppo R; Troyanov S; Bellur S; Cattran D; Cook HT; Feehally J; Roberts IS; Morando L; Camilla R; Tesar V; Lunberg S; Gesualdo L; Emma F; Rollino C; Amore A; Praga M; Feriozzi S; Segoloni G; Pani A; Cancarini G; Durlik M; Moggia E; Mazzucco G; Giannakakis C; Honsova E; Sundelin BB; Di Palma AM; Ferrario F; Gutierrez E; Asunis AM; Barratt J; Tardanico R; Perkowska-Ptasinska A;
Kidney Int; 2014 Oct; 86(4):828-36. PubMed ID: 24694989
[TBL] [Abstract][Full Text] [Related]
12. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies.
Hill GS; Karoui KE; Karras A; Mandet C; Van Huyen JD; Nochy D; Bruneval P
Kidney Int; 2011 Mar; 79(6):635-642. PubMed ID: 21160460
[TBL] [Abstract][Full Text] [Related]
13. Focal segmental glomerulosclerosis in mild IgA nephropathy: a clinical-pathologic study.
Weber CL; Rose CL; Magil AB
Nephrol Dial Transplant; 2009 Feb; 24(2):483-8. PubMed ID: 18786972
[TBL] [Abstract][Full Text] [Related]
14. IgA nephropathy histologically resembling focal-segmental glomerulosclerosis: a clinicopathologic study of 18 cases.
Haas M
Am J Kidney Dis; 1996 Sep; 28(3):365-71. PubMed ID: 8804234
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.
Chakera A; MacEwen C; Bellur SS; Chompuk LO; Lunn D; Roberts ISD
J Nephrol; 2016 Jun; 29(3):367-375. PubMed ID: 26318019
[TBL] [Abstract][Full Text] [Related]
16. Podocyte injury as a potential therapeutic target in IgA nephropathy: should pathology guide us?
Haas M
Kidney Int; 2024 Jun; 105(6):1165-1167. PubMed ID: 38777401
[TBL] [Abstract][Full Text] [Related]
17. Clinical and histological differences between adults and children in new onset IgA nephropathy.
Cambier A; Rabant M; El Karoui K; Peuchmaur M; Servais A; Hertig A; Deschenes G; Salomon R; Hogan J; Robert T
Pediatr Nephrol; 2020 Oct; 35(10):1897-1905. PubMed ID: 32444925
[TBL] [Abstract][Full Text] [Related]
18. Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions.
Cheng P; Xie Q; Liu S; Liu X; Wang L; Hao CM
Rev Assoc Med Bras (1992); 2024; 70(4):e20230871. PubMed ID: 38716932
[TBL] [Abstract][Full Text] [Related]
19. Cellular focal segmental glomerulosclerosis: Clinical and pathologic features.
Stokes MB; Valeri AM; Markowitz GS; D'Agati VD
Kidney Int; 2006 Nov; 70(10):1783-92. PubMed ID: 17021605
[TBL] [Abstract][Full Text] [Related]
20. CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.
Mariani LH; Bomback AS; Canetta PA; Flessner MF; Helmuth M; Hladunewich MA; Hogan JJ; Kiryluk K; Nachman PH; Nast CC; Rheault MN; Rizk DV; Trachtman H; Wenderfer SE; Bowers C; Hill-Callahan P; Marasa M; Poulton CJ; Revell A; Vento S; Barisoni L; Cattran D; D'Agati V; Jennette JC; Klein JB; Laurin LP; Twombley K; Falk RJ; Gharavi AG; Gillespie BW; Gipson DS; Greenbaum LA; Holzman LB; Kretzler M; Robinson B; Smoyer WE; Guay-Woodford LM;
Am J Kidney Dis; 2019 Feb; 73(2):218-229. PubMed ID: 30420158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
